Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Zai Collaborates with Geneseeq to Implement Personalized Cancer Care

publication date: Oct 14, 2021

Zai Lab of Shanghai will collaborate with Geneseeq Technology, a Toronto-China company, to integrate cutting-edge NGS services into clinical trials and advance precision care. The two companies will form business relationships based on Geneseeq's clinical trial patient recruitment, central laboratory testing, companion diagnostics development and marketing services for Zai's cancer candidates. Zai has three cancer products approved in China and another 10-15 candidates in development, many of them based on companion biomarkers. More details....

Stock Symbol: (NSDQ: ZLAB; HK: 9688)

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here


BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here


Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here